Placebo Control
A review of key issues in pharmaceutical clinical trials
Showing posts with label
Duke
.
Show all posts
Showing posts with label
Duke
.
Show all posts
Tuesday, June 4, 2013
Can FDA's New Transparency Survive Avandia?
›
PDUFA V commitments signal a strong commitment to tolerance of open debate in the face of uncertainty. I can admit to a rather powerful la...
Monday, August 13, 2012
Most* Clinical Trials Are Too** Small
›
* for some value of "most" ** for some value of "too" [Note: this is a companion to a previous post, Clouding the Deba...
›
Home
View web version